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Summary
Smartphone health applications (‘apps’) are widely available but experts remain
cautious about their utility and safety. We reviewed currently available apps for the
detection of melanoma (July 2014), aimed at general community, patient and gen-
eralist clinician users. A proforma was used to extract and assess each app that met
the inclusion criteria, and we undertook content analysis to evaluate their content
and the evidence applied in their development. Thirty-nine apps were identified
with the majority available only for Apple users. Over half (n = 22) provided infor-
mation or education about melanoma, ultraviolet radiation exposure prevention
advice, and skin self-examination strategies, mainly using the ABCDE (A, Asymme-
try; B, Border; C, Colour; D, Diameter; E, Evolving) method. Half (n = 19) helped
users take and store images of their skin lesions either for review by a dermatologist
or for self-monitoring to identify change, an important predictor of melanoma; a
similar number (n = 18) used reminders to help users monitor their skin lesions. A
few (n = 9) offered expert review of images. Four apps provided a risk assessment
to patients about the probability that a lesion was malignant or benign, and one
app calculated users’ future risk of melanoma. None of the apps appeared to have
been validated for diagnostic accuracy or utility using established research methods.
Smartphone apps for detecting melanoma by nonspecialist users have a range of
functions including information, education, classification, risk assessment and
monitoring change. Despite their potential usefulness, and while clinicians may
choose to use apps that provide information to educate their patients, apps for
melanoma detection require further validation of their utility and safety.
What’s already known about this topic?
• Earlier detection of melanoma would allow timely treatment and could improve
outcomes.
• Although smartphone applications (‘apps’) are recognized as having potentially
wide use in dermatology and oncology, experts have expressed caution concerning
their diagnostic utility and safety.
What does this study add?
• We identified almost 40 smartphone apps available to detect or prevent melanoma
by nonspecialist users including previously unaffected individuals, patients previ-
ously diagnosed with skin cancer, and generalist clinicians.
• Most apps gave advice or education about melanoma, ultraviolet radiation exposure
preventive advice, and skin self-examination strategies; half of the apps enabled
patients to capture and store images of their skin lesions either for review by a der-
matologist or for self-monitoring to identify change, an important predictor of
melanoma; only four apps provided a risk assessment about a skin lesion.
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• There was little evidence of clinical or research-based input into the design of these
apps or of evaluation of their utility, so clinicians should be cautious about sup-
porting the use of such apps to detect melanoma.
Smartphones are rapidly evolving from being solely devices
for communication and entertainment to include specialized
applications (‘apps’) that are intimately involved in many
aspects of daily life. A vast range of health apps is now avail-
able to assist users (> 13 000 in a 2012 report), for example
to monitor their pulse and blood pressure, or to track their
food intake and exercise undertaken to manage weight loss.
Furthermore, two out of three U.S. clinicians already use
smartphone health apps in their practice to manage a range of
conditions.1 Some apps have been evaluated, such as those to
assist in managing diabetes2 and pain,3 and to aid monitoring
of anticoagulation therapy4 and epilepsy,5 but such evaluation
is not common among apps aimed at general community
users, probably due to the rapid evolution and commercial
drivers of this field. While smartphones have been hailed as
‘new clinical tools in oncology’,1 many experts remain cau-
tious about the utility of the thousands of apps currently avail-
able, either free or at a small charge, for the prevention,
detection and management of cancer.6,7 It has also been sug-
gested that apps for detecting cancers tend to lack scientific
and specialty input,8 and the use of technology to deliver can-
cer follow-up has only begun to be studied for safety and util-
ity: a recently published systematic review found only two
randomized studies that had used smartphone technology.9
A number of dermatology-specific apps have been devel-
oped which aim to help previously unaffected individuals or
those previously diagnosed with a skin cancer to decide if they
should seek medical review for a skin lesion,10,11 and to assist
nonspecialist clinicians such as general practitioners (GPs) to
make decisions about whether to reassure the patient that their
lesion is benign or to refer for specialist assessment.10 How-
ever, a recent comparison of the accuracy of four smartphone
apps in assessing melanoma risk demonstrated wide variation
in performance and utility.7 Furthermore, smartphone apps
for the identification or management of cancer including mel-
anoma have not been subject to any sort of validation or regu-
latory controls in the U.S.A., the U.K. or elsewhere. Therefore,
while they have the potential to improve patient and nonspe-
cialist clinician assessment and patient–clinician communica-
tion about potential skin cancer there is the risk that these
apps could actually harm users. The advice could be inaccurate
or misleading, apps could be used as a substitute for a clinical
consultation, and they could even delay melanoma diagno-
sis.12 This risk is particularly concerning for melanoma com-
pared with other cancers as the majority are detected by the
patient rather than their clinician, and the time taken to
present to a clinician from first noticing a skin change or
symptom is longer than for all other cancers except those of
the head and neck.13
In this paper we report a review of currently available
smartphone apps for the detection of melanoma aimed at gen-
eral community, patient or generalist clinician users, evaluat-
ing their content and the evidence applied in their
development.
Methods
In July 2014 we searched the online stores of the two most
popular smartphone providers (Apple14 and Android,15 which
together provide more than 90% of cancer-related apps6), for
health apps that suggested any kind of support for previously
unaffected individuals, or those previously diagnosed with a
skin cancer, to detect melanoma. Our search terms included
‘skin cancer’, ‘mole’ and ‘melanoma’. We assessed the
descriptions of each app identified by the searches, and
included in this review all apps that stated an aim to help to
detect melanoma. We excluded all apps that aimed to provide
entertainment, cosmetics advice or general medical informa-
tion alone. We also excluded those designed only for use by
skin cancer specialists (dermatologists and plastic surgeons)
including apps which use a dermoscopy attachment to the
phone, but included any aimed specifically at generalist clini-
cians. We also excluded apps that were not available in Eng-
lish.
We developed a proforma specifically for this review, and
one researcher (A.P.K.) extracted data about all the apps that
met the inclusion criteria. The proforma was completed based
only on the online descriptions; no apps were downloaded for
data extraction purposes. All included apps were evaluated for
their operating systems (Apple, Android, both), whether they
were derived from research and/or validated, and the year of
the latest update. The included apps were also evaluated for
(i) general information about melanoma and/or skin cancer,
ultraviolet radiation (UVR) and sun exposure preventive
advice, and skin self-examination strategies; (ii) risk factor
assessment; (iii) cataloguing and/or classifying using ‘image
analysis’, defined as a comparison between the lesion and a
stored image or an algorithm to assess the image, or the for-
warding of images to a dermatologist; and (iv) monitoring
changes in moles over time.
Content analysis and critical appraisal were then performed
independently by two researchers (A.P.K. and F.M.W.) to
analyse the findings and refine the categories. The emerging
categories were discussed and critiqued by all the experienced
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researchers, whose differing perspectives and expertise facili-
tated a robust and critical interpretation of assigned themes,
and discussion and resolution of any differences by consensus.
Results
We identified 39 unique smartphone apps that met our inclu-
sion criteria (Tables 1 and 2). Most are available for Apple
Inc. devices only (26, 667%), with eight available for
Android devices only (205%), and just five available for both
platforms (128%).
Properties of available smartphone apps
Table 1 demonstrates the 39 smartphone apps currently avail-
able (July 2014) for previously unaffected individuals or those
previously diagnosed with a skin cancer in the online stores of
the two main application providers. Most of the apps (n = 28)
were available to download for free, with the remaining apps
having an added cost to download (range £069–£499).
Table 2 shows the properties and functions of these apps.
The commonest function was to provide general information
about melanoma and/or skin cancer (n = 22). Nineteen apps
catalogued and classified lesions by capturing images, and
applying integral algorithms, and 18 apps aimed to monitor
skin lesions.
Information about melanoma and/or skin cancer was pro-
vided in a number of ways including access to online libraries.
The ABCDE method (A, Asymmetry; B, Border; C, Colour; D,
Diameter; E, Evolving) was most commonly used to provide
education about skin self-examination and self-assessment of
moles (n = 12).16 Most of the apps provided more than one
type of function. For example, the Mollie’s Fund app provided
information on skin self-examination, the ABCDE method, and
how to protect from UVR exposure; and the UMSkinCheck
app provided information about the ABCDE method, the com-
monest types of skin lesions, and how to protect against UVR
exposure. Four apps (Dermatology Planet, iDoc24, Skin Can-
cer, Skin of Mine) also offered guidance on how to find a der-
matologist in the U.S.A. One app (UMSkinCheck) stated it was
specifically designed for non-Hispanic white U.S. citizens.
Cataloguing and classifying lesions was mainly undertaken
by comparing the users’ own photographic images obtained
by the smartphone against a set of exemplar images, such as
in Embarrassing Bodies – My MoleChecker. Some apps con-
tained integral algorithms for photographic analysis such as
pattern recognition and real-time computer image analysis
technology in Doctor Mole and SpotMole, enabling the user to
take a photographic image of the mole for assessment of each
of the ABCDE criteria, and reporting changes in the features of
the mole compared with previous photographic images. One
app, Melanoma Visual Risk Calculator, used a Visual Analogue
Scale (VAS) to compare the user’s skin lesion against the
ABCDE criteria. It was noteworthy that seven apps (Mole
Detective, Mole Monitor, Skin of Mine, Skin Prevention –
Photo Body Map, Skin Scanner, Skin Vision, SkinXM) provided
limited or no information on how the photographic images
were processed and analysed to provide advice on likelihood
of melanoma. Apps from Apple Inc. are available for iPhones,
iPads and iPod touch with software 3.1.3 and later, and apps
from Android for all Android phones with software 1.6 and
up. A minority of apps (n = 9), such as Dermlink.md and
Mole Check App, offered prompt expert review of images
taken by the user. These were often accompanied by advice
on making an appointment with a dermatologist, and func-
tioned only in the U.S.
Using smartphone apps to monitor skin lesions was under-
taken via the storage of photographic images of their skin
lesions. Users were encouraged to track the evolution of indi-
vidual lesions by comparing serial images over time. While
some such as Doctor Mole and Skin Prevention used simple
comparisons with stored images, others used more sophisti-
cated algorithms, such as Skin Analytics, which claimed to use
‘real time vision technology’. Some, such as the Doctor Mole
app, provided feedback to patients based on the ABCDE
method; others, such as the Embarrassing Bodies – My Mole-
Checker and the Mole Detective apps allowed users to set
reminders to take another photograph for comparison after a
selected time. These apps also suggested that users could share
the images during consultations with their dermatologist or
family physician.
Only four apps provided tools to assess a skin lesion for
likelihood of melanoma. The Doctor Mole and Skin Doctor
apps used a computerized algorithm based on the ABCDE
method, and the Melanoma Visual Risk Calculator provided a
risk approximation based on patients’ responses to a VAS.
iSkin claimed to gather information about a mole and then
calculate risk of melanoma, but provided no further informa-
tion about the method involved.
A single app offered assessment of a person’s baseline risk
factor: UMSkinCheck used eight risk factors (region, sex, race,
age, complexion, tanning, small moles and freckling) to calcu-
late 5-year absolute risk for melanoma. However, there was
no information about the model used to underpin this calcula-
tion.
Development and performance of apps
Even though several of the apps incorporated the ABCDE
method, only one app acknowledged any research and devel-
opmental processes; the Melanoma Visual Risk Calculator was
based on the diagnostic value of the ABCDE criteria for patient
users.17 Clinician involvement in the development of apps was
clearly stated in only four apps. None of the apps were
reported to have been validated.
Version updates
Among the apps, the range of latest updates was 2009–14,
with 17 updated in 2013–14, nine in 2012, seven in 2011,
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Table 1 Smartphone applications for melanoma detection by nonspecialist users including previously unaffected individuals, patients previously
diagnosed with skin cancer, and generalist clinicians
Name Owner/developer
Country
of origin Type Cost Provider
Latest
update
(year)
Notes (from application
descriptions in the online
stores only)
1 ABCDEs of
melanoma
Mouhammad
Aouthmany
U.S.A. Cl. Free Android 2013 Provides information on the
ABCDE method, and a game
aiming to identify abnormal
moles
2 Dermatology
Planet
Edizioni Scripta
Manent snc
Italy Co. Free Apple 2013 Provides daily news and skin
cancer information, and
helps U.S. user to identify a
dermatologist; available for
patient and provider use
3 Dermlink.md Dermlink Inc. U.S.A. Co. Free Apple 2013 Allows user to take a
photographic image of a
mole and send to a U.S.
dermatologist; the user
receives a diagnosis within
24 h
4 Doctor Mole –
Skin Cancer
App
RevoSoft/Mark
Shippen
Australia Co. £399 Both 2014 App;
2013
Android
Provides information on the
ABCDE method. Contains a
risk calculator (based on
ABCDE method) with real-
time computer vision
technology aiming to assess
changes in moles. Enables
setting of reminders to
monitor moles
5 Embarrassing
Bodies – My
MoleChecker
Channel 4 U.K. Co. Free Apple 2012 Tracks moles by taking and
storing photographic images
and comparing them with
standard images. Contains a
‘mole gallery’, self-
examination videos, and
enables setting of reminders
to monitor moles
6 Embarrassing
Bodies – My
SelfChecker
Channel 4 U.K. Co. Free Apple 2012 Provides information on skin
self-examinations among
other self-checks. Enables
setting of reminder to
monitor moles together
with self-check videos,
information about skin
checks and the ABCDE
method
7 FotoSkin Wake App Health SL Spain Co. Free Apple 2014 Allows user to monitor their
skin using a photographic
register, and to show the
images to their health
professional. Also offers
information about skin
conditions, skin protection,
and preventing skin cancer
© 2015 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
British Journal of Dermatology (2015) 172, pp1507–1518
1510 Smartphone applications for melanoma detection, A.P. Kassianos et al.
Table 1 (continued)
Name Owner/developer
Country
of origin Type Cost Provider
Latest
update
(year)
Notes (from application
descriptions in the online
stores only)
8 iDoc24 –
Ask the
dermatologist
today!
iDoc24 AB Sweden Co. Free Apple 2014 Allows user to send
photographic image plus
personal and lesion
information (age, sex,
description, duration,
changes in appearance, size,
location, symptoms) to
anonymous dermatologist
service with reply within
24 h. Also provides
information about skin
conditions, and helps to
identify a dermatologist
9 iSkin David Klotz; 2009
Mobile Otis
U.S.A. Co. £069 Apple 2009 Requires information from
the user about their mole
and calculates risk of
melanoma. If high risk,
urges user to seek medical
help. It also provides a list
of their responses for the
user to discuss with their
clinician
10 LoveMySkin –
Mole map
for skin
cancer
prevention
Steven Romej U.S.A. Co. £069 Apple 2011 Provides a photographic
image of the user’s body to
mark spots that the user
wishes to monitor. Also
provides information on the
ABCDE method
11 Melanoma
iABCD rule
Mindexs Brazil Co. Free Apple 2012 Provides information about
the ABCDE method and on
how to differentiate a
malignant from a benign
mole
12 Melanoma
Visual Risk
Calculator
Sigve Dhondup
Holmen MD
Norway Cl. Free Apple 2011 Provides a VASa for each of
the ABCDE criteria; user can
then assess their lesion and
receive melanoma risk
information
13 Melanoma
Watch
Stroika U.K. Co. Free Apple 2010 Guides user to learn the
difference between
malignant and benign
moles. Compares the user’s
moles with stored images.
Provides information about
moles and the ABCDE
method
14 Mole Check
App
Botomap Inc. U.S.A. Co. Free Apple 2014 Allows a photographic image
to be taken and assessed by
a dermatologist. Requires a
fee to submit image
© 2015 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
British Journal of Dermatology (2015) 172, pp1507–1518
Smartphone applications for melanoma detection, A.P. Kassianos et al. 1511
Table 1 (continued)
Name Owner/developer
Country
of origin Type Cost Provider
Latest
update
(year)
Notes (from application
descriptions in the online
stores only)
15 Mole Checker Stroika U.K. Co. Free Apple 2010 Guides user to learn the
difference between
malignant and benign
moles, and how to self-
examine, with information
about ABCDE method.
Compares moles with stored
photographic images
16 Mole Checker Harry Arden U.K. Co. Free Android 2011 Guides user to learn skin self-
examination. Contains the
same description as the
‘Melanoma Watch’
application
17 Mole Detective Lascarow Healthcare
Technologies Ltd
U.K. Co. £304 Android 2012 Allows a photographic image
to be taken and stored, and
analyses using the ABCDE
method, giving melanoma
risk information. Compares
pictures over time, and
enables user to set
reminders to monitor their
moles
18 Mole Monitor Pro-Cal Powertrain
Development
U.K. Co. £499 Apple 2014 Analyses and monitors mole
images using an algorithm.
Images are compared with
previous ones uploaded and
the user is provided with a
report, which the health
provider can refer to
19 MoleQuest ProjectProject Pty Ltd U.S.A. Co. Free Apple 2013 The user captures two images
and answers a few ‘Yes/No’
questions. Responses and
photographic images are
forwarded to a
dermatologist for reviewing.
The user is provided with a
report with
recommendations by the
dermatologist
20 MoleTrac Depthmine Software U.S.A. Co. £069 Apple 2011 A photographic diary aiming
to educate the user to track
changes in moles. Requires
information on
characteristics such as size,
colour and thickness
21 Mollie’s Fund MCS Advertising.
Mollie Biggane
Melanoma
Foundation
U.S.A. Ch. Free Both 2011 App;
2013
Android
Provides information about
ABCDE method, skin self-
monitoring and sun
protection. Enables user to
keep track of their self-
exams with Monthly Skin
Check logs
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Table 1 (continued)
Name Owner/developer
Country
of origin Type Cost Provider
Latest
update
(year)
Notes (from application
descriptions in the online
stores only)
22 nevus Shonik IDEAS U.S.A. Co. £199 Both 2012 App;
2013
Android
Allows user to track their
moles by using a Skin
Record. Provides
information about sun
protection, tips and product
recommendations from
dermatologists, and
information on abnormal
moles
OnlineDermClinic.com LLC
U.S.A.
23 OnlineDerm
Clinic
OnlineDermClinic.
com LLC
U.S.A. Co. Free Both 2014 Allows user to take
photographic images and
answer a few skin-related
questions. Information and
image are forwarded to a
U.S.A. dermatologist for
response within 48 h.
24 Skin Analytics Skin Analytics
Development
U.K. Co. Free Both 2014 Allows user to take and
compare photographic
images over time. It also
requires information such as
living location, but it is not
explained how this
information is used
25 Skin Cancer Andrew Kaufman,
MD
U.S.A. Cl. Free Apple 2014 Provides information about
types of skin cancers and
their treatment. Allows user
to upload photographic
images, and enables user to
identify a dermatologist and
request an appointment
26 Skin Cancer
Information
Anima U.S.A. Co. Free Android 2011 Provides information ranging
from symptom management
to skin cancer diagnosis and
available treatments
27 Skin Doctor Ibrahim Salim
Alhalabi
U.S.A. Co. Free Android 2014 Compares uploaded
photographic images with
stored images to evaluate
melanoma risk, using an
algorithm based on the
ABCDE method
28 Skin Mole
Analysis
Opticom Data
Research
Canada Co. Free Android 2012 Provides access to an online
database of moles and their
risk analysis. Provides
information about a device
called MoleSense, and
allows user to upload a
photographic image and
receive a dermatologist’s
report within a week
29 Skin of Mine Medical Image
Mining Laboratories
U.S.A. Co. Free Apple 2011 Analyses and tracks
photographic images, and
refers user to a licensed
dermatologist in certain U.S.
states
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Table 1 (continued)
Name Owner/developer
Country
of origin Type Cost Provider
Latest
update
(year)
Notes (from application
descriptions in the online
stores only)
30 Skin
Prevention –
Photo Body
Map for
Melanoma
and Skin
Cancer Early
Detection
Dimension S.r.l. Italy Co. £499 Apple 2014 Allows user to upload
photographic images to
monitor skin changes by
comparisons with previous
images. It is described as
promoted by the
International Society of
Dermatoscopy
31 Skin Scanner Intelligent Life
Solutions
Portugal Co. £069 Apple 2012 Scans mole area in order to
monitor the moles. It then
provides information on
moles that need observation
and skin counselling.
Enables user to set
reminders to monitor their
moles. Permits forwarding
of photographic images to
the user’s dermatologist
32 SkinTagger Coriumedic Systems
LLC
U.S.A. Co. Free Apple 2014 Annotates corresponding site
of lesion on a model to
facilitate tracking of
changes. Contains
information about ABCDE
method
33 SkinVision SkinVision B.V. Netherlands Co. £069 Apple 2014 Creates instant analyses of
mole photographic images
and provides information
on how to improve skin
health and determine
personal UVR exposure to
prevent melanoma
34 SkinXM AlternateUniverse
Technologies
U.S.A. Co. £299 Apple 2012 Allows user to monitor their
moles using image analysis
tools to compare images for
changes
35 SpotCheck 2 SpotCheck
Applications Inc.
U.S.A. Co. Free Apple 2013 Provides information and
images to differentiate
between a malignant or
benign mole, based on
ABCDE method. Provides
access to dermatologist
review of photographic
images within 24 h. Not
available in England
36 SpotMole Cristian Munteanu Spain Co. Free Android 2014 Detects signs of melanoma
using image processing and
pattern recognition
techniques
37 Track-A-Mole Peak Mobile Designs
LLC
U.S.A. Co. Free Android 2011 Creates slideshow projects for
user’s moles. Enables user
to set monthly reminders to
monitor their moles.
Contains information about
ABCDE method
© 2015 The Authors. British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
British Journal of Dermatology (2015) 172, pp1507–1518
1514 Smartphone applications for melanoma detection, A.P. Kassianos et al.
two in 2010 and one in 2009. Three apps (Doctor Mole –
Skin Cancer app, Mollie’s Fund, nevus) had their Apple and
Android versions updated in different years.
Discussion
This review has identified smartphone apps for detecting
melanoma by nonspecialist users including previously unaf-
fected individuals, patients previously diagnosed with skin
cancer, and generalist clinicians. We have evaluated the con-
tent of the apps with respect to general information about
melanoma and/or skin cancer, UVR and sun exposure pre-
ventive advice, skin self-examination strategies, assessment of
current and future melanoma risk, personal or expert image
analysis to classify lesions, and lesion monitoring over time.
We have identified 39 smartphone apps with the majority
available only for Apple users. One-third of these apps pro-
vided information only. A similar number enabled patients
to capture and store images of their skin lesions either for
review by a dermatologist or for self-monitoring to identify
change, an important predictor of melanoma. Four apps pro-
vided a risk assessment to patients about the probability that
a lesion was malignant or benign, and only one app incor-
porated a validated risk model giving individuals information
about their future risk of melanoma. None of the apps
appeared to have been validated for diagnostic accuracy or
utility using established research methods. There was limited
information about whether the apps were developed with
clinician involvement, and some apps had not been updated
for more than 3 years.
While a recent systematic review of smartphone apps for
the prevention, detection and management of cancer in gen-
eral concluded that there has been ‘a lot of action, but not in
the right direction’, as they tend not to incorporate technolog-
ical innovation,6 we have identified a range of uses of smart-
phone technology for melanoma detection. For example,
image analysis allows for self-monitoring, and the use of
reminders and alerts promote the added use of monitoring
skin changes over time. Furthermore, the technology can use
a ‘teledermatology’ model, and send the image for expert
review and advice. Nevertheless, one-third of the apps that we
identified only promoted awareness of cancer symptoms or
solar protection, with no potential for interaction or specialist
overview, despite the strong evidence suggesting that the pro-
vision of information alone is not an effective intervention to
improve patient self-management of chronic disease in pri-
mary care.6,18 Adding self-monitoring techniques could be
more effective than information-provision alone.19 Moreover,
as communication with clinicians may improve adherence to
e-healthcare interventions,20 apps that facilitate communica-
tion with skin specialists may have utility, particularly for
individuals previously diagnosed with a skin cancer.
Almost a quarter of the apps used a teledermatology model
to send the image for expert review. Evaluations of remote
Table 1 (continued)
Name Owner/developer
Country
of origin Type Cost Provider
Latest
update
(year)
Notes (from application
descriptions in the online
stores only)
38 UMSkinCheck University of
Michigan
U.S.A. Un. Free Apple 2012 Allows user to complete and
store a full-body
photographic survey, set up
self-exam prompt, track
detected lesions, and fill out
a melanoma risk calculator.
Provides information about
ABCDE method, images of
common skin lesions, sun
safety and sunscreen.
Provides a risk calculator for
5-year absolute melanoma
risk. Area-specific to the
U.S.A. and only for non-
Hispanic whites
39 YourSkinDiary Buiss Ultimo GmbH.
Danne Montague-
King
Australia Co. Free Apple 2012 Allows user to capture
photographic images and
tracks changes. Contains UV
index level information of
the user’s area
ABCDE (A, Asymmetry; B, Border; C, Colour; D, Diameter; E, Evolving); Ch., charity; Cl., clinical; Co., commercial; Un., university; UV,
ultraviolet; UVR, UV radiation; VAS, visual analogue scale. aA VAS is a psychometric response scale, which indirectly measures variables that
cannot be directly measured.
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assessment of clinical photographs and/or dermoscopic images
have given good diagnostic values (up to 98% sensitivity),
suggesting the likely reliability of this method in smartphone
apps assuming adequate image quality.21–24 Most evaluations
describe dermatologists or plastic surgeons as experts, but a
fully qualified dermatologist may not need to support skin
Table 2 Properties of smartphone applications for melanoma detection by nonspecialist users including previously unaffected individuals, patients
previously diagnosed with skin cancer, and generalist clinicians
Name
Information and/or education
Risk factor
assessment
Cataloging/classifying
Monitoring/
tracking
Melanoma/
skin cancer
UVR/sun
exposure
advice
Skin
self-
examination
Image
analysisa
Dermatologists
review
1 ABCDEs of melanoma  
2 Dermatology Planet 
3 Dermlink.md 
4 Doctor Mole – Skin Cancer Appb     
5 Embarrassing Bodies – My
MoleCheckerb
   
6 Embarrassing Bodies – My
SelfChecker
  
7 FotoSkin     
8 iDoc24 – Ask the
dermatologist today!
 
9 iSkin 
10 LoveMySkin – Mole map for skin
cancer prevention
  
11 Melanoma iABCD rule  
12 Melanoma Visual Risk Calculatorf  
13 Melanoma Watchg   
14 Mole Check App 
15 Mole Checker (by Stroika)g   
16 Mole Checker (by Harry Arden)  
17 Mole Detectiveh  
18 Mole Monitorb  
19 MoleQuest 
20 MoleTrac 
21 Mollie’s Fund   
22 nevus   
23 OnlineDermClinic 
24 Skin Analytics 
25 Skin Cancer 
26 Skin Cancer Information 
27 Skin Doctorh  
28 Skin Mole Analysisi    
29 Skin of Minef   
30 Skin Prevention – Photo Body Map
for Melanoma and Skin Cancer
Early Detectionc
 
31 Skin Scannerc   
32 SkinTagger  
33 Skin Visionb   
34 SkinXMd  
35 SpotCheck 2c   
36 SpotMolei 
37 Track-A-Mole   
38 UMSkinChecke      
39 YourSkinDiaryf   
Total 22 6 15 4 18 9 19
ABCDE (A, Asymmetry; B, Border; C, Colour; D, Diameter; E, Evolving); UVR, ultraviolet radiation. aDefined as comparison between lesion
and a stored image; brequires iOS 60 or later; crequires iOS 51 or later; drequires iOS 50 or later; erequires iOS 43 or later; frequires iOS
40 or later; grequires iOS 313 or later; hrequires Android 22 and up; irequires Android 21 and up; jrequires Android 16 and up.
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apps, and there could be roles for generalist clinicians and
allied health professionals, particularly if using a dermoscope
attached to a phone.25 Fewer apps used automated image
analysis for skin self-examination. While this is clearly feasi-
ble,26 there is less clear evidence around its diagnostic accu-
racy or utility. Indeed, a recent report highlighted the
diagnostic inaccuracies of four smartphone apps for melanoma
detection, with wide variations in sensitivity and specificity to
detect malignant skin lesions.7
Twelve apps made use of the ABCDE method27 to inform
and educate users. The Doctor Mole and Skin Doctor apps also
used a computerized algorithm based on the ABCDE method
to help people assess the risk of melanoma directly for a spe-
cific lesion. Most apps that we identified were developed in
the U.S.A. where the ABCDE method is widely used, even
though there is evidence that the revised ‘Glasgow’ 7-point
checklist has higher sensitivity for diagnosing cutaneous mela-
noma when compared with the ABCDE method.28 Future apps
could consider incorporating and validating the 7-point check-
list for melanoma detection, particularly for use in the U.K.
population where it was developed and recently validated in a
primary care population.29 Two apps were not included in the
review as they were marketed for doctor’s use only. iDoc24
Pro was the ‘professional’ version of iDoc24, aiming to ‘help
clinicians assess whether to refer a patient to a dermatologist’,
and Melanoma Risk Assessment Tool (Apple; last updated
2011) used the patient’s personal and medical history and the
result of a back and shoulders examination to calculate an esti-
mate of a patient’s absolute melanoma risk.
We found that some apps have not been updated for more
than 3 years. Even when updated recently, there was no dis-
cussion around whether the updates were based on new evi-
dence, and we were not able to distinguish whether
commercial or other apps were updated most regularly. We
also found surprisingly scanty scientific evidence about the
development or evaluation of the smartphone apps included
in our review; only one app provided a single reference to a
peer-reviewed publication. Reviews of smartphone apps for
dermatology in general,7,11 and for colorectal cancer,8 have
reported similar findings. There seems to be a profound mis-
match between the promise of the app developers on the one
hand and evidence of clinical validity and utility on the other
hand, as demonstrated in this study. This is of concern for
two reasons: firstly, it is important to establish the safety,
including accuracy and utility, of these apps, particularly as
the market is unregulated; secondly, clinicians may be benefit-
ing financially from both the sale of the apps and the teleder-
matology role, and this should be disclosed.
Strengths and limitations
Previous reviews of smartphone apps focused mainly on
those developed by Apple Inc.3,30 This review extends
knowledge to apps for melanoma detection developed by
Google. This is the first review that evaluates the content of
smartphone apps available for melanoma detection for previ-
ously unaffected individuals or those previously diagnosed
with a skin cancer, and generalist clinicians. It is also the
first review to outline the content of available apps, whether
they are derived from research evidence, and whether they
have been validated.
We recognize that there are limitations to this review. It
was restricted to the descriptions available from the online
stores; more information may have been available after pur-
chasing or using the apps, but this was not undertaken in
order to ensure equity across the review. Moreover, we felt
that users should be able to make an informed choice about
the apps by reading their description in the online stores. We
reviewed apps only available in English; therefore we may
have failed to identify any apps published in other languages.
In reality this is unlikely as the U.S.A. and U.K. were the main
countries publishing these apps, with a few also coming from
Western Europe and South America. Finally, we only reviewed
apps applicable to Apple and Android phones as we knew that
more than 90% of apps are available via these two platforms.
It is likely that small platforms would use the same apps – as
some were available via both of the major platforms – and we
are therefore confident that few are missing.
Clinical and policy implications
A recent systematic review mapping mobile health research
over the last decade identified 117 publications, but concluded
that few included large or rigorous evaluation of the novel
technologies.31 Another recent review has also identified
patients as having a stronger desire to be informed about
underpinning scientific evidence than commercial stakehold-
ers.32 Our review has shown little evidence of clinical- or
research-based input; therefore, more research is needed to
evaluate their content, validity and utility to support detection
of melanoma in previously unaffected individuals and those
previously diagnosed with a skin cancer. A particular priority
should be to evaluate how skin self-monitoring could help
people appraise their skin changes and make appropriate help-
seeking decisions. Without a more explicit research base, clini-
cians should be cautious about supporting the use of such
apps to detect melanoma earlier, although they may choose to
use apps for education and/or information alone. It is note-
worthy that although the U.S. Food and Drug Administration
(FDA) does not currently regulate the mobile health industry,
there are plans to do so in a similar way to regulation for
medical devices;33 the European Medicines Agency has
signalled similar intentions.34 Further evidence on clinical
validity and utility are likely to be required for these
regulators.
Nevertheless, these apps continue to have great potential.35
Ideally, evidence is needed on the diagnostic accuracy of these
tools in the hands of intended users compared with a refer-
ence standard diagnosis. If shown to be accurate, trials of their
clinical utility would be needed to assess their cost-effective-
ness in promoting earlier diagnosis and reducing consultations
for benign lesions. Evidence-based smartphone apps could
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then contribute towards minimizing the diagnostic delay expe-
rienced by people with melanoma, which may be significantly
associated with mortality.36
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